Ecker + Ecker GmbH
Since the DVG came into force, Ecker + Ecker has supported DiGA manufacturers from the assessment of DiGA eligibility through the entire Fast Track procedure to price negotiations with the GKV-Spitzenverband.
Strategic advice on reimbursement; preparation and support for BfArM consultations; support with evidence generation: from study planning through conduct to analysis; assistance with preparing the listing application; support throughout the Fast Track procedure: assistance with deficiency notices; preparation and support for reimbursement price negotiations with the GKV-Spitzenverband (incl. negotiation simulations); interactive tools for calculating the reimbursement price; support in arbitration proceedings
Ecker + Ecker can draw on solid experience from DiGA projects across all process steps. In addition, Ecker + Ecker continuously monitors the development of the DiGA market as well as all prices, price negotiation outcomes and arbitration board decisions for DiGA and derives recommendations from them. Ecker + Ecker also draws on more than 10 years of experience in market access for pharmaceuticals, diagnostics and medical devices.
